Nanjing Dorra Pharmaceutical Technology Co., Ltd.

Group that researches, manufactures and sells pharmaceutical active ingredients and intermediates, cosmetic ingredients, veterinary actives and formulations. Its technologies include bromination, enzyme and metal catalysis, nitration and hydrogenation. It runs three plants in Hubei and Gansu with three thousand cubic metres of reactor capacity, and reports GMP approvals from China, the European Union, the FDA and Japan.